Thalidomide-Dexamethasone for Multiple Myeloma

NCT00038090 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]